Radiation oncologists from the Paracelsus Medizinische Privatuniversität in Salzburg, Austria, presented findings of a nonrandomized study comparing ipsilateral breast cancer recurrence in patients treated for invasive breast cancer. The lead author of the study was Roland Reitsamer, MD.
The researchers evaluated the outcomes of 378 patients: Of this group, 188 received conventional radiation therapy with a boost at the end of treatment, and 190 received an IOERT boost during the breast conservation surgery before undergoing conventional radiation therapy.
All patients received 51-56 Gy of radiation delivered with conventional electron-beam radiation therapy. The women who had a single fraction of IOERT received an intraoperative electron boost of 9 Gy, whereas the other group received a 12-Gy boost upon completing the course of treatment.
Patients in the two groups were comparable with respect to age, menopausal status, tumor size, histological type, grading, and axillary lymph node status, Reitsamer said. All patients had clear margins greater than 3 mm. Patients diagnosed with ductal carcinoma in situ were excluded, as well as those with multicentric disease.
A comparison of 10-year actuarial rates of ipsilateral breast cancer recurrence showed that excellent local control was achieved for the group that received a boost at the time of treatment.
|10-year recurrent rates: conventional versus IOERT boost
|Ipsilateral breast tumor recurrence
|True local recurrence
By Cynthia E. Keen
AuntMinnie.com staff writer
December 14, 2010
Electronic breast brachytherapy does well for APBI and IORT, September 22, 2010
Midtreatment boost during WBRT reduces skin dermatitis, September 9, 2010
Intraoperative radiotherapy good alternative after breast-conserving surgery, September 19, 2002
Copyright © 2010 AuntMinnie.com